Vitamin K antagonists in pregnancy: An overestimated risk?

• References

• 1 Robert E, Guibaud P. Maternal Valproic acid and congenital neural tube defects. Lancet 1982; 02: 937.
• 2 Artama M, Auvinen A, Raudaskoski T. et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005; 64: 1874-8.
• 3 Shepard TH, Brent RL, Friedman JM. et al. Update on new developments in the study of human teratogens. Teratology 2002; 65: 153-61.
• 4 Schaefer C, Hannemann D, Meister R. et al. Vitamin K antagonists and pregnancy outcome. A multicentre prospective study. Thromb Haemost 2006; 95: 949-57.
• 5 van Driel D, Wesseling J, Sauer PJ. et al. In utero exposure to coumarins and cognition at8 to 14 years old. Pediatrics 2001; 107: 123-9.
• 6 Schaefer C, Hannemann D, Meister R. Post-marketing surveillance system for drugs in pregnancy - 15 years experience of ENTIS. Reprod Toxicol 2005; 20: 331-43.
• 7 Martinez-Frias ML, Rodriguez-Pinilla E. The problems of using data from teratology information services (TIS) to identify putative teratogens. Teratology 1999; 60: 54-5.
• 8 Ornoy A, Mastroiacovo P. More on data from teratogen information systems (TIS). Teratology 2000; 61: 327-8.
• 9 Johnson KA, Weber PA, Jones KL. et al. Selection bias in teratology information service pregnancy outcome studies. Teratology 2001; 64: 79-82.
• 10 Einarson A, Ahmed F, Gallo M. et al. Reproducibility of medical information obtained via the telephone vs personal interview. Vet Human Toxicol 1999; 41: 397-400.
• 11 Felix RJ, Jones KL, Johnson KA. et al., for the Organization of Teratology Information Services (OTIS) Collaborative Research Group. Postmarketing surveillance for drug safety in pregnancy:The Organization of Teratology Information Services Project. Birth Defects Research (A) 2004; 70: 944-7.